Showing results (61-70 of 114) with videos related to

Sort By:
Pageof 12
Aging|January 9, 2024
Effectiveness and safety of afatinib, gefitinib, and erlotinib for treatment-naïve elderly patients with epidermal growth factor receptor-mutated advanced non-small-cell lung cancer: a multi-institute retrospective studyLing-Jen Hung, Ping-Chih Hsu, Cheng-Ta Yang, et al.
Cancers|February 10, 2026
Correction: Wu et al. WIP1 Inhibition by GSK2830371 Potentiates HDM201 Through Enhanced p53 Phosphorylation and Activation in Liver Adenocarcinoma Cells. Cancers 2021, 13, 3876Chiao-En Wu, Ahmed Khairallah Mahdi, Chen-Yang Huang, et al.
Asia-Pacific Journal of Clinical Oncology|May 19, 2011
An indirect comparison of bevacizumab plus cisplatin-gemcitabine and cisplatin plus pemetrexed treatment for patients with advanced first-line non-squamous non-small cell lung cancer in East AsiaJohn Wen-Cheng Chang, Sumitra Thongprasert, Elaine Wright, et al.
Life (Basel, Switzerland)|November 11, 2020
Chromosomal Instability May Not Be a Predictor for Immune Checkpoint Inhibitors from a Comprehensive Bioinformatics AnalysisChiao-En Wu, Da-Wei Yeh, Yi-Ru Pan, et al.
Medicine|October 19, 2019
Merkel cell carcinoma in Taiwan: A series of 24 cases and literature reviewJohn Wen-Cheng Chang, Yao-Yu Chang, Yen-Lin Huang, et al.
JAMA Network Open|September 1, 2020
Type of Androgen Deprivation Therapy and Risk of Dementia Among Patients With Prostate Cancer in TaiwanWen-Kuan Huang, Chi-Hung Liu, See-Tong Pang, et al.
Anticancer Research|March 29, 2022
Real-world Afatinib Outcomes in Advanced Non-small Cell Lung Cancer Harboring EGFR MutationsChi-Han Chen, John Wen-Cheng Chang, Ching-Fu Chang, et al.
Cancers|October 27, 2022
Impact of T790M Mutation Status on Later-Line Osimertinib Treatment in Non-Small Cell Lung Cancer PatientsYan-Jei Tang, John Wen-Cheng Chang, Ching-Fu Chang, et al.
Thoracic Cancer|August 1, 2023
Comprehensive assessment of pretreatment sarcopenia impacts on patients with EGFR-mutated NSCLC treated with afatinibChen-Te Wu, Ping-Chih Hsu, John Wen-Cheng Chang, et al.
Asia-Pacific Journal of Clinical Oncology|August 5, 2016
A comparison of immunohistochemical and molecular methods used for analyzing the BRAF V600E gene mutation in malignant melanoma in TaiwanWen-Kuan Huang, Tseng-Tong Kuo, Chiao-En Wu, et al.
Pageof 12